High efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin for 12 weeks in treatment of genotype 1b HCV infected cirrhotic patients: A large real world cohort

Authors
Category Primary study
JournalHepatology
Year 2016
This article has no abstract
Epistemonikos ID: e1055dac22a3cb64fa88c9a5489906cfcff0113a
First added on: Feb 08, 2025